Aortic stenosis and mitral regurgitation modify the effect of venoarterial extracorporeal membrane oxygenation on left ventricular function in cardiogenic shock.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 10 2022
12 10 2022
Historique:
received:
17
07
2022
accepted:
28
09
2022
entrez:
12
10
2022
pubmed:
13
10
2022
medline:
15
10
2022
Statut:
epublish
Résumé
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is widely used in the treatment of patients experiencing cardiogenic shock (CS). However, increased VA-ECMO blood flow (EBF) may significantly impair left ventricular (LV) performance. The objective of the present study was to assess the effect of VA-ECMO on LV function in acute CS with concomitant severe aortic stenosis (AS) or mitral regurgitation (MR) in a porcine model. Eight female swine (45 kg) underwent VA-ECMO implantation under general anaesthesia and mechanical ventilation. Acute CS was induced by global myocardial hypoxia. Subsequently, severe AS was simulated by obstruction of the aortic valve, while severe MR was induced by mechanical destruction of the mitral valve. Haemodynamic and LV performance variables were measured at different rates of EBF rates (ranging from 1 to 4 L/min), using arterial and venous catheters, a pulmonary artery catheter, and LV pressure-volume catheter. Data are expressed as median (interquartile range). Myocardial hypoxia resulted in declines in cardiac output to 2.7 (1.9-3.1) L/min and LV ejection fraction to 15.2% (10.5-19.3%). In severe AS, increasing EBF from 1 to 4 L/min was associated with a significant elevation in mean arterial pressure (MAP), from 33.5 (24.2-34.9) to 56.0 (51.9-73.3) mmHg (P ˂ 0.01). However, LV volumes (end-diastolic, end-systolic, stroke) remained unchanged, and LV end-diastolic pressure (LVEDP) significantly decreased from 24.9 (21.2-40.0) to 19.1 (15.2-29.0) mmHg (P ˂ 0.01). In severe MR, increasing EBF resulted in a significant elevation in MAP from 49.0 (28.0-53.4) to 72.5 (51.4-77.1) mmHg (P ˂ 0.01); LV volumes remained stable and LVEDP increased from 17.1 (13.7-19.1) to 20.8 (16.3-25.6) mmHg (P ˂ 0.01). Results of this study indicate that the presence of valvular heart disease may alleviate negative effect of VA-ECMO on LV performance in CS. Severe AS fully protected against LV overload, and partial protection was also detected with severe MR, although at the cost of increased LVEDP and, thus, higher risk for pulmonary oedema.
Identifiants
pubmed: 36224296
doi: 10.1038/s41598-022-21501-z
pii: 10.1038/s41598-022-21501-z
pmc: PMC9556561
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17076Informations de copyright
© 2022. The Author(s).
Références
EuroIntervention. 2021 Feb 05;16(15):e1227-e1236
pubmed: 33106225
J Transl Med. 2015 Aug 15;13:266
pubmed: 26275717
Ann Thorac Surg. 2001 Mar;71(3):868-71
pubmed: 11269466
Physiol Res. 2016 Nov 8;65(4):711-715
pubmed: 27824481
Eur J Heart Fail. 2015 May;17(5):501-9
pubmed: 25820680
Eur Heart J. 2020 Oct 7;41(38):3753-3761
pubmed: 33099278
Am Heart J. 2021 Apr;234:1-11
pubmed: 33428901
Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E542-51
pubmed: 23554044
Eur J Heart Fail. 2017 May;19 Suppl 2:124-127
pubmed: 28470919
Crit Care Med. 2008 May;36(5):1404-11
pubmed: 18434909
Ann Thorac Surg. 2001 Mar;71(3):862-7
pubmed: 11269465
Interv Cardiol Clin. 2021 Apr;10(2):221-234
pubmed: 33745671
JACC Cardiovasc Interv. 2021 Dec 27;14(24):2698-2707
pubmed: 34949394
Clin Res Cardiol. 2021 Sep;110(9):1412-1420
pubmed: 33180150
PLoS One. 2018 Apr 24;13(4):e0196321
pubmed: 29689088
Membranes (Basel). 2021 Mar 16;11(3):
pubmed: 33809568
J Transl Med. 2020 Feb 13;18(1):75
pubmed: 32054495
Gen Thorac Cardiovasc Surg. 2017 Jun;65(6):329-336
pubmed: 28236098
Ann Transl Med. 2016 Aug;4(16):306
pubmed: 27668226
ASAIO J. 2016 Jan-Feb;62(1):e1-4
pubmed: 26309098
J Am Soc Echocardiogr. 2012 Jun;25(6):632-40
pubmed: 22421027
Cardiol Res Pract. 2019 Dec 09;2019:3869603
pubmed: 31885900
J Pediatr. 1991 Mar;118(3):431-6
pubmed: 1999787
Perfusion. 2019 Jul;34(5):354-363
pubmed: 30632894
J Cardiovasc Transl Res. 2010 Dec;3(6):625-34
pubmed: 20848344
Artif Organs. 1999 Nov;23(11):966-9
pubmed: 10564298
J Pediatr Surg. 1992 Jan;27(1):48-53
pubmed: 1552444
Pediatr Cardiol. 1992 Jul;13(3):141-5
pubmed: 1603713